In this podcast, Mark Pimentel, MD, talks about the American College of Gastroenterology's new clinical guideline on small intestinal bacterial overgrowth (SIBO), how the guideline attempts to clear up the controversies around diagnosis and treatment of SIBO, and more. More at: www.consultant360.com/gastroenterology

While researchers originally explored sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide (GLP)-1 receptor agonists for their impact on blood glucose, the two classes of agents were unexpectedly found to have cardiovascular benefits. In this podcast, Ralph Brindis, MD, MPH, interviews Laurence Sperling, MD, about implementing SGLT2 inhibitors and GLP-1 receptor agonists into the treatment of patients with cardiovascular disease and diabetes. For more, click here: www.consultant360.com/cardiology

In this podcast, George Karpouzas, MD, talks about his research on highly sensitive cardiac troponin-I and IgA antibodies against β-2 glycoprotein 1 in the setting of coronary atherosclerosis among patients with rheumatoid arthritis. More at: www.consultant360.com/rheumatology

In this podcast, George Karpouzas, MD, discusses his research that evaluated whether β-2 glycoprotein 1 IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of inflammation on atherosclerosis among patients with rheumatoid arthritis. More at: www.consultan360.com/rheumatology

In this podcast, George Karpouzas, MD, talks about his study that evaluated whether biologic disease-modifying antirheumatic drugs reduce long-term risk of cardiovascular events in patients with rheumatoid arthritis, as well as their mechanism of action. More at: www.consultant360.com/rheumatology.

In this podcast, George Karpouzas, MD, talks about his study that evaluated the impact of inflammation, cardiac risk factors, duration of medication exposure, and their interactions on coronary plaque progression among patients with rheumatoid arthritis. More at: www.consultant360.com/rheumatology.

In this podcast, J. Antonio Aviña-Zubieta, MD, MSc, PhD, from the University of British Columbia, discusses his research on the overall risk and temporal trends of venous thromboembolism, deep vein thrombosis, and pulmonary embolism in patients with gout, as well as how rheumatologists can approach management. More at: www.consultant360.com/rheumatology

In this podcast, Dr Eiras discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has changed his practice. For more, visit www.consultant360.com/infectious-diseases.

In this podcast, Valerie Delpech, MBBS, MPH, speaks about her session at CROI 2020, which was focused on UK HIV epidemic and the programs that were implemented that helped reduce the number of HIV infections in the region. More at: www.consultant360.com/infectious-diseases

In this podcast, Veronique Morinville, MDCM, from Montreal Children's Hospital, talks about the latest NASPGHAN position paper on roles of endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) in the evaluation and treatment of chronic pancreatitis in children. More at: www.consultant360.com/gastroenterology